Trial Profile
Phase III trial of bupropion/zonisamide in patients with obesity.
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 19 Mar 2013
Price :
$35
*
At a glance
- Drugs Bupropion/zonisamide (Primary)
- Indications Obesity
- Focus Therapeutic Use
- 19 Mar 2013 New trial record